Literature DB >> 9000236

Description of an improved method for Blastocystis hominis culture and axenization.

M D Lanuza1, J A Carbajal, J Villar, R Borrás.   

Abstract

An improved method for Blastocystis hominis culture and axenization was developed in the present study. Stool samples were cultured in prereduced Boeck-Drbohlav NHI modified medium (with several modifications) supplemented with antibiotics (0.4% ampicillin, 0.1% streptomycin, 0.0006% amphotericin B). Axenization was performed by the combination of partial purification of B. hominis by Ficoll-metrizoic acid gradient and inoculation in fresh medium containing active antibiotics against remaining bacteria. A total of 25 strains were obtained by this procedure. The time required for axenization ranged between 3 and 5 weeks. The generation time of axenic strains ranged from 6.6 to 12.1 h (mean +/- SD 110.0 +/- 1.8 h) and the mean number of generations was 2.5 +/- 0.6 h per 24 h. The size of vacuolar and ameboid forms found in stools and in culture was similar. The special formulation of the medium used reduced the generation time and did not modify the cellular size as compared with fecal forms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9000236     DOI: 10.1007/s004360050209

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  17 in total

1.  PCR fingerprinting of Blastocystis isolated from symptomatic and asymptomatic human hosts.

Authors:  T C Tan; K G Suresh; K L Thong; H V Smith
Journal:  Parasitol Res       Date:  2006-04-21       Impact factor: 2.289

Review 2.  Methods for cultivation of luminal parasitic protists of clinical importance.

Authors:  C Graham Clark; Louis S Diamond
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

3.  Effects of symptomatic and asymptomatic isolates of Blastocystis hominis on colorectal cancer cell line, HCT116.

Authors:  Kok Hoe Chan; Samudi Chandramathi; Kumar Suresh; Kek Heng Chua; Umah Rani Kuppusamy
Journal:  Parasitol Res       Date:  2012-01-26       Impact factor: 2.289

4.  Predominance of amoeboid forms of Blastocystis hominis in isolates from symptomatic patients.

Authors:  T C Tan; K G Suresh
Journal:  Parasitol Res       Date:  2005-12-02       Impact factor: 2.289

5.  High prevalence of subtype 4 among isolates of Blastocystis hominis from symptomatic patients of a health district of Valencia (Spain).

Authors:  M Victoria Domínguez-Márquez; Remedios Guna; Carlos Muñoz; M Teresa Gómez-Muñoz; Rafael Borrás
Journal:  Parasitol Res       Date:  2009-05-27       Impact factor: 2.289

6.  Amoeboid form of Blastocystis hominis - a detailed ultrastructural insight.

Authors:  T C Tan; K G Suresh
Journal:  Parasitol Res       Date:  2006-07-01       Impact factor: 2.289

7.  Morphology and reproductive mode of Blastocystis hominis in diarrhea and in vitro.

Authors:  X Zhang; J Y Qiao; X J Zhou; F R Yao; Z C Wei
Journal:  Parasitol Res       Date:  2007-01-11       Impact factor: 2.289

8.  Distribution and phylogenetic analysis of Blastocystis sp. subtypes isolated from IBD patients and healthy individuals in Iran.

Authors:  H Mirjalali; M R Abbasi; N Naderi; Z Hasani; E S Mirsamadi; C R Stensvold; H Balaii; H Asadzadeh Aghdaei; M R Zali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-25       Impact factor: 3.267

Review 9.  New insights on classification, identification, and clinical relevance of Blastocystis spp.

Authors:  Kevin S W Tan
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

10.  Molecular epidemiology of Blastocystis spp. in children referred to Qods hospital in northwest of Iran.

Authors:  Soheila Rahimi Niaraki; Elham Hajialilo; Asma Delshad; Safar Ali Alizadeh; Mahmood Alipour; Peyman Heydarian; Mehrzad Saraei
Journal:  J Parasit Dis       Date:  2019-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.